Alcohol, tobacco and cannabis use among French school students in 2018
Tendances n° 132, OFDT, 4 p.
In 2018, two major international surveys Health Behaviour in School-aged Children (HBSC) and European School Project on Alcohol and other Drugs (ESPAD) were carried out simultaneously for the first time in France, using a unified scientific framework. More than 20,000 middle school and high school students, representing 11- to 18-year-old adolescents attending secondary school in metropolitan France, were invited to answer an online questionnaire on their well-being and health behaviour, including their use of psychoactive substances. This collaboration between surveys, which is unprecedented in Europe, makes it possible to measure this use among all students from Grade 6 to 12. This issue of Tendances presents the prevalence of experimentation and use of the three most widely used substances during adolescence: alcohol, tobacco and cannabis, by school grade. While adolescence is the main period where alcohol, tobacco and cannabis are experimented with, the timing and progression of substance use vary:
- Alcohol, which is mainly experimented with during middle school, is still the first substance used during adolescence, followed by tobacco.
- The consumption of cannabis tends to begin at the end of middle school, with experimentation and use developing and strengthening during high school. It is still the most common illegal product, while the lifetime use of other illegal substances remains really low.
EnCLASS data also confirms the ready accessibility of the products, despite the fact that it is illegal to sell tobacco and alcohol to minors.
Authors : Stanislas Spilka, Emmanuelle Godeau (EHESP), Olivier Le Nézet, Virginie Ehlinger (Inserm UMR 1027), Eric Janssen, Alex Brissot, Antoine Philippon, Sandra Chyderiotis
Download the PDF file (476 Ko)
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.
Country drug reports 2019
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.